MacroGenics
MGNX
#9146
Rank
โ‚ฌ94.07 M
Marketcap
1,49ย โ‚ฌ
Share price
3.24%
Change (1 day)
-41.22%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: โ‚ฌ94.07 Million

As of February 2026 MacroGenics has a market cap of โ‚ฌ94.07 Million. This makes MacroGenics the world's 9146th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ94.07 M8.51%
2025โ‚ฌ86.69 M-55.5%
2024โ‚ฌ0.19 B-63.91%
2023โ‚ฌ0.53 B40.37%
2022โ‚ฌ0.38 B-55.74%
2021โ‚ฌ0.86 B-16.88%
2020โ‚ฌ1.04 B

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of MacroGenics was reported to be:

โ‚ฌ91.12 Million
by Nasdaq info icon info icon
โ‚ฌ91.12 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ130.30 B 138,408.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ838.45 B 891,137.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ173.20 B 184,013.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ157.27 B 167,072.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ261.41 B 277,770.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ105.52 B 112,070.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.69 B 635.85%๐Ÿ‡บ๐Ÿ‡ธ USA